[Study on evaluation of human immunodeficiency virus reverse transcriptase inhibitor by ELISA]

Area of Science:

• Biochemistry
• Molecular Biology
• Enzyme Assays

Context:

• Reverse transcriptase (RT) is crucial for retroviral replication and is a key target for antiviral therapies.
• Existing methods for detecting RT activity can be complex and time-consuming.
• There is a need for a sensitive, specific, and efficient assay for RT activity and inhibitor screening.

Purpose:

• To develop and validate an enzyme-linked immunosorbent assay (ELISA) for quantifying reverse transcriptase activity.
• To establish a reliable method for screening potential inhibitors of reverse transcriptase.
• To evaluate the performance characteristics of the developed ELISA method.

Summary:

• An ELISA method was established by immobilizing oligo (dT)15 to microtiter plates and detecting biotin-dUTP incorporation by reverse transcriptase using a streptavidin-alkaline phosphatase reporter system.
• The assay demonstrated stability, repeatability, specificity, and sensitivity, and was successfully used to test the inhibitory activity of PFA and NVP, as well as to study the kinetic mechanisms of AMV-RT and HIV-1 RT.
• The developed ELISA assay offers advantages of simplicity, speed, specificity, and minimal environmental impact.

Impact:

• Provides a valuable tool for the discovery and development of novel reverse transcriptase inhibitors.
• Facilitates research into the mechanisms of retroviral enzymes.
• Enables high-throughput screening of potential antiviral compounds against HIV-1 and other retroviruses.